Haopeng Sun

Title: Haopeng Sun: Innovator in Pharmaceutical Chemistry

Introduction

Haopeng Sun is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for various medical conditions. With a total of three patents to his name, his work focuses on addressing critical health issues, including Alzheimer's disease and anemia.

Latest Patents

One of Haopeng Sun's latest patents is a selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof. This invention discloses a compound that selectively inhibits butyrylcholinesterase, demonstrating promising efficacy in treating Alzheimer's disease, especially in moderate to severe cases. The compound has shown good target activity in vitro, high selectivity, and drug safety, making it a potential lead substance for further development in Alzheimer's treatment.

Another significant patent is related to alkynyl pyridine prolyl hydroxylase inhibitors. This invention highlights a class of compounds that effectively inhibit prolyl hydroxylase, enhancing the generation and secretion of erythropoietin. This advancement can be beneficial in treating or preventing anemia, particularly in chronic kidney disease and ischemic diseases, including strokes and myocardial ischemia.

Career Highlights

Haopeng Sun has worked with prominent institutions, including China Pharmaceutical University and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Throughout his career, Haopeng Sun has collaborated with notable colleagues, including Qidong You and Xiaojin Zhang. These partnerships have fostered innovation and advancement in their respective fields.

Conclusion

Haopeng Sun's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of critical health conditions.